Aurinia Pharmaceuticals Q3 EPS $0.23 Beats $0.22 Estimate, Sales $83.699M Beat $83.691M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.22 by 4.55 percent. This is unchanged from the same period last year. The company
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.22 by 4.55 percent. This is unchanged from the same period last year. The company reported quarterly sales of $83.699 million which beat the analyst consensus estimate of $83.691 million by 0.01 percent. This is a 13.93 percent increase over sales of $73.468 million the same period last year.